StockData
Connect Biopharma Holdings Ltd logo

Connect Biopharma Holdings Ltd (CNTB) stock

CNTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.58−0.06 (-9.98%)

Close on Nov 17, 2026Market cap $36.45MP/E –Yield –

Connect Biopharma operating margin

Operating margin is operating income as a percentage of revenue.

Connect Biopharma's operating margin for the twelve months ending Jun 30, 2026 was -2384.5%. For fiscal 2025 it was -90740.6%, against -86.2% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-90740.6%−90654.4
FY2024Dec 31, 2024-86.2%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-636.0%+742.1
Q1 FY2026Mar 31, 2026-11601.8%−10465.9
Q3 FY2025Sep 30, 2025-110481.3%−110537.8
Q2 FY2025Jun 30, 2025-27966.7%–
Q4 FY2024Dec 31, 2024-1378.1%–
Q3 FY2024Sep 30, 2024-1135.8%–
Q2 FY2024Jun 30, 202456.6%–

More Connect Biopharma figures

See a number that looks wrong?